(AI) C3 Ai - Overview
Sector: Technology | Industry: Software - Infrastructure | Exchange: NYSE (USA) | Market Cap: 1.350m USD | Total Return: -61.2% in 12m
Avg Turnover: 39.5M
Qual. Beats: -1
Rev. Trend: 76.4%
Qual. Beats: -1
Warnings
Interest Coverage Ratio -4.9 is critical
Altman Z'' -14.98 < 1.0 - financial distress zone
Fakeout
Tailwinds
No distinct edge detected
C3.ai, Inc. is an enterprise artificial intelligence (AI) software provider that develops and deploys application-specific solutions across various industrial and government sectors. The company’s core offering is the C3 Agentic AI platform, which serves as an integrated development and runtime environment for building enterprise-scale AI applications. Its product portfolio includes specialized suites for customer relationship management (CRM), healthcare, financial services, supply chain optimization, and sustainability management.
The company operates within the Systems Software sub-industry, utilizing a Software-as-a-Service (SaaS) business model that prioritizes recurring subscription revenue. This model is characterized by high scalability and deep integration into client workflows, particularly through strategic cloud partnerships with Microsoft Azure, AWS, and Google Cloud. Enterprise AI adoption often requires significant computational resources and data integration capabilities to move from pilot programs to full-scale production environments.
C3.ai also provides mission-critical tools for defense, intelligence, and local government agencies, including applications for law enforcement and property appraisal. The firm’s generative AI capabilities focus on retrieving and presenting information from disparate enterprise data stores to improve decision-making. You can explore further technical analysis and valuation metrics on ValueRay to deepen your understanding of this stock. Headquartered in Redwood City, California, the company maintains alliances with major consultancy and industrial firms like McKinsey & Company and Baker Hughes to drive industry-specific AI implementation.
- Enterprise AI platform adoption drives subscription revenue
- Strategic partnerships expand market reach and sales channels
- Generative AI product suite boosts competitive positioning
- Government contract awards secure significant revenue streams
| Net Income: -434.5m TTM > 0 and > 6% of Revenue |
| FCF/TA: -0.14 > 0.02 and ΔFCF/TA -10.77 > 1.0 |
| NWC/Revenue: 215.9% < 20% (prev 216.1%; Δ -0.15% < -1%) |
| CFO/TA -0.14 > 3% & CFO -125.6m > Net Income -434.5m |
| Net Debt/EBITDA: error (EBITDA <= 0) |
| Current Ratio: 6.58 > 1.5 & < 3 |
| Outstanding Shares: last quarter (138.7m) vs 12m ago 6.36% < -2% |
| Gross Margin: 43.45% > 18% (prev 0.60%; Δ 4.29k% > 0.5%) |
| Asset Turnover: 31.51% > 50% (prev 34.77%; Δ -3.26% > 0%) |
| Interest Coverage Ratio: -4.91 > 6 (EBITDA TTM -452.7m / Interest Expense TTM 95.1m) |
| A: 0.74 (Total Current Assets 782.7m - Total Current Liabilities 118.9m) / Total Assets 895.8m |
| B: -1.94 (Retained Earnings -1.73b / Total Assets 895.8m) |
| C: -0.48 (EBIT TTM -466.3m / Avg Total Assets 975.5m) |
| D: -9.83 (Book Value of Equity -1.73b / Total Liabilities 176.3m) |
| Altman-Z'' = -14.98 = D |
| DSRI: 0.82 (Receivables 123.6m/180.4m, Revenue 307.4m/366.9m) |
| GMI: 1.38 (GM 43.45% / 59.95%) |
| AQI: 1.18 (AQ_t 0.05 / AQ_t-1 0.04) |
| SGI: 0.84 (Revenue 307.4m / 366.9m) |
| TATA: -0.34 (NI -434.5m - CFO -125.6m) / TA 895.8m) |
| Beneish M = -3.20 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 9.29 with a total of 4,426,068 shares traded.
Over the past week, the price has changed by +7.40%,
over one month by +7.52%,
over three months by -8.20% and
over the past year by -61.16%.
C3 Ai has received a consensus analysts rating of 2.93. Therefore, it is recommended to hold AI.
- StrongBuy: 3
- Buy: 1
- Hold: 6
- Sell: 2
- StrongSell: 3
| Analysts Target Price | 8.8 | -5.1% |
P/S = 4.391
P/B = 1.876
Revenue TTM = 307.4m USD
EBIT TTM = -466.3m USD
EBITDA TTM = -452.7m USD
Long Term Debt = unknown (none)
Short Term Debt = 4.79m USD (from shortTermDebt, last fiscal year)
Debt = 10.2m USD (from shortLongTermDebtTotal, last fiscal year) + Leases 5.37m
Net Debt = -78.7m USD (calculated: Debt 10.2m - CCE 88.8m)
Enterprise Value = 1.27b USD (1.35b + Debt 10.2m - CCE 88.8m)
Interest Coverage Ratio = -4.91 (Ebit TTM -466.3m / Interest Expense TTM 95.1m)
EV/FCF = -10.00x (Enterprise Value 1.27b / FCF TTM -127.0m)
FCF Yield = -10.00% (FCF TTM -127.0m / Enterprise Value 1.27b)
FCF Margin = -41.33% (FCF TTM -127.0m / Revenue TTM 307.4m)
Net Margin = -141.4% (Net Income TTM -434.5m / Revenue TTM 307.4m)
Gross Margin = 43.45% ((Revenue TTM 307.4m - Cost of Revenue TTM 173.8m) / Revenue TTM)
Gross Margin QoQ = 17.34% (prev 40.43%)
Tobins Q-Ratio = 1.42 (Enterprise Value 1.27b / Total Assets 895.8m)
Interest Expense / Debt = 934.9% (Interest Expense 95.1m / Debt 10.2m)
Taxrate = 21.0% (US default 21%)
NOPAT = -368.4m (EBIT -466.3m * (1 - 21.00%)) [loss with tax shield]
Current Ratio = 6.58 (Total Current Assets 782.7m / Total Current Liabilities 118.9m)
Debt / Equity = 0.01 (Debt 10.2m / totalStockholderEquity, last quarter 719.5m)
Debt / EBITDA = 0.17 (negative EBITDA) (Net Debt -78.7m / EBITDA -452.7m)
Debt / FCF = 0.62 (negative FCF - burning cash) (Net Debt -78.7m / FCF TTM -127.0m)
Total Stockholder Equity = 782.1m (last 4 quarters mean from totalStockholderEquity)
RoA = -44.54% (Net Income -434.5m / Total Assets 895.8m)
RoE = -17.27% (Net Income TTM -434.5m / Total Stockholder Equity 2.52b)
RoCE = -60.03% (EBIT -466.3m / Capital Employed (Total Assets 895.8m - Current Liab 118.9m))
RoIC = -53.54% (negative operating profit) (NOPAT -368.4m / Invested Capital 688.0m)
WACC = 12.77% (E(1.35b)/V(1.36b) * Re(12.87%) + (debt cost/tax rate unavailable))
Discount Rate = 12.87% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 89.89 | Cagr: 8.17%
[DCF] Fair Price = unknown (Cash Flow -127.0m)
EPS Correlation: N/A | EPS CAGR: N/A | SUE: -1.69 | # QB: -1
Revenue Correlation: 76.40 | Revenue CAGR: 11.28% | SUE: -2.51 | # QB: -1
EPS current Quarter (2026-07-31): EPS=-0.28 | Chg30d=+0.00% | Revisions=-20% | Analysts=13
[Analyst] Revisions Ratio: -20%